Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dialysis Withdrawal”

8 trials

Showing 8 of 8 results

Large-scale testing (Phase 3)Ended earlyNCT05786469
What this trial is testing

Patiromer Trial in CKD Stage IIIB to V

Who this might be right for
Hyperkalemia
Mario Negri Institute for Pharmacological Research 2
Large-scale testing (Phase 3)Study completedNCT00416520
What this trial is testing

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseHyperphosphatemia
Tanabe Pharma Corporation 336
Not applicableLooking for participantsNCT07309367
What this trial is testing

Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice'

Who this might be right for
Kidney Failure, Chronic Therapy; Hemodialysis
Duke-NUS Graduate Medical School 100
Not applicableStudy completedNCT04375358
What this trial is testing

Creatinine Clearance as a Predictor of Successful Withdrawl of Continuous Renal Replacement Therapy in Intensive Care

Who this might be right for
Dialysis WithdrawalCreatinine Clearance
Centre Hospitalier Universitaire Dijon 64
Large-scale testing (Phase 3)Study completedNCT00858637
What this trial is testing

Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis

Who this might be right for
Chronic Kidney Disease
Tanabe Pharma Corporation 260
Early research (Phase 1)Study completedNCT05533008
What this trial is testing

CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients

Who this might be right for
Hemodialysis
Cara Therapeutics, Inc. 35
Large-scale testing (Phase 3)Study completedNCT03427125
What this trial is testing

Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis

Who this might be right for
Hyperphosphatemia
Ardelyx 1,559
Large-scale testing (Phase 3)Study completedNCT00506441
What this trial is testing

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 245

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation